Exelon Corporation (NASDAQ: EXC) — The Cheapest Utility, Cheap for a Reason in Illinois

Independent fundamental research. Sections 1–15 below take no position and set no price target; the single exception is the Claude's Take block immediately below, which is the author’s own opinion. This article is general information, not investment advice.

⚡ Claude’s Take

This block is the author’s own subjective opinion. It is general information, not investment advice. The analysis in the sections below takes no position and sets no price target.

Verdict: HOLD — a structurally sound but below-average-quality regulated franchise trading at a deserved discount that is now mostly priced in. Accumulate on weakness, do not chase, not a short. Directional zone: I would treat ~15x forward operating EPS and below — roughly the low-$40s, a >3.8% yield, ~1.4x book — as the accumulation zone where the Illinois discount over-compensates and the ~7.9% rate-base growth plus transmission optionality are had close to free. From ~17x forward operating EPS and up (high-$40s / ~$49–50, the March-2026 high, ~1.7x book) the forward return is essentially just the ~3.6% yield plus mid-single-digit EPS growth, with the multiple at the 88th percentile of its own decade offering no further help and a live regulatory/affordability overhang offering plenty of downside. This is a defensive-value / bond-proxy-with-a-regulatory-hair, not a momentum trend and emphatically not a quality compounder you overpay for.

The variant worth holding is what the discount is actually paying you for. EXC is the cheapest large-cap regulated utility — ~16x forward operating EPS versus AEP/DUK/SO/D at ~18–21x — and the bull frames that as a closing-discount opportunity on a company with above-median (~7.9%) rate-base growth, an ~80%-transmission-weighted capital plan routed through its best regulator (FERC), an ~18 GW data-center pipeline, and 5–7% EPS growth guided “near the top end.” The bear — and where I lean — says the discount is the market correctly pricing the lowest earned ROE in the cohort (~9.0–9.6%), an Illinois regulatory regime that rejected ComEd’s grid plan and set an 8.905% allowed ROE with a punitive 50% equity layer (now under appeal), and a fresh, self-inflicted crack in the growth story: in April 2026 PECO withdrew its Pennsylvania rate cases citing affordability after the governor’s “justifiable returns” letter — the first concrete sign that the bill-fatigue backlash now bites EXC where two of its six jurisdictions live. The tape agrees it is no compounder: beta ~0.04, a dominant LowVolatility loading, a +12% trailing year that is a falling-rate/yield re-rate (the same one that lifted AEP), and a recent 3-month pullback — defensive, not momentum, not a falling knife. Conviction: low-to-medium. Flips bullish: ComEd winning a materially better ROE/equity ratio on appeal or in the 2028–2031 grid plan (order due Dec-15-2026) and earned consolidated ROE printing toward 10%. Flips bearish: the Pennsylvania affordability regime hardening into a structurally lower allowed ROE/equity cap that spreads to Maryland, or a PECO/Pepco-Holdings credit downgrade as the capex deficit funds through a tightening balance sheet.

The honest tension: on an absolute basis EXC is not cheap — it sits at the 88th percentile of its own ten-year valuation (P/B 93rd, P/S 93rd) — yet relative to peers it carries the group’s largest discount, and that discount is the cleanest thing about the thesis: it is roughly fair. You are paid a 3.6% yield and ~6% EPS growth to own a protected monopoly whose single most important regulator is also its most hostile. That is a HOLD, not a table-pounding value call. Catchy version: a fortress with a cracked foundation in Springfield — buy the discount, don’t pay up for the franchise.

📈 Stock Price Action — Five-Year Event Map

Over the trailing five years EXC’s split-and-spin-adjusted line ran from roughly $27 (mid-2021) to a $49.82 all-time-high close on 16-Mar-2026, and sits at $45.81 (18-Jun-2026) — about 8% off the high, inside a 52-week range of ~$40.8–$49.8. The shape is two regimes: ~three years of post-spin “dead money” (2022–2024) followed by a 2025–early-2026 re-rating on the AI/load-growth-plus-falling-rates utility trade, then a spring-2026 pullback on a Pennsylvania affordability shock. (Prices are AZI split/dividend-adjusted; pre-Feb-2022 levels are scaled for the Constellation spin distribution, so the early line understates the then-quoted whole-company price.)

Cycle narrative. (1–2) EXC rallied into the long-telegraphed Constellation separation, which closed 1-Feb-2022 and left a clean regulated-wires company — the structural event that defines the modern EXC [Exelon 8-K, Feb 2022]. (3) The freshly-simplified utility caught a defensive bid through the 2022 bear market. (4) Then nothing for three years: the 2022–23 Fed hiking cycle is the classic enemy of a bond-proxy utility, and the Illinois Commerce Commission’s December-2023 rejection of ComEd’s multi-year Grid Plan — and the subsequent 8.905% allowed ROE — capped the stock’s most important earnings engine [ICC Dkt. 23-0055, Dec-2023]. (5) From late 2024 EXC re-rated with the entire regulated cohort as data-center load turned utilities into “AI infrastructure” and the market began pricing rate cuts — the same yield-and-growth re-rate that carried AEP, DUK and SO to their own highs; EXC’s ~$38B (later $41.7B) transmission-weighted plan and ~18 GW data-center pipeline gave it a credible growth hook [Exelon Q4-2025 / Q1-2026 disclosures]. (6) The spring-2026 pullback is company-specific: PECO’s April-2026 withdrawal of its Pennsylvania electric and gas rate cases, made under affordability pressure and a pointed letter from Governor Shapiro on “justifiable returns,” reminded the market that EXC’s growth runs through politically exposed regulators [Exelon Q1-2026 earnings call, 6-May-2026]. The price move in each row is Fact; the attributed cause is Interpretation.

1. Executive Summary

Exelon is the largest pure-play regulated electricity and gas transmission and distribution (T&D) company in the United States — a holding company over six state-regulated monopoly utilities serving ~10.7 million customers across the Mid-Atlantic and Illinois: ComEd (Chicago/northern Illinois), PECO (Philadelphia, electric + gas), BGE (Baltimore, electric + gas), and the three Pepco Holdings utilities — Pepco (Washington DC + suburban Maryland), Delmarva Power/DPL (Delaware + Maryland), and Atlantic City Electric/ACE (southern New Jersey). All six sit inside the PJM Interconnection. Since spinning off its generation arm, Constellation Energy (CEG), on 1 February 2022, Exelon owns no power plants — it is a pure “wires” delivery business whose earnings are governed by the regulated formula rate base × allowed ROE (on the equity layer) + recovery of debt cost, O&M, depreciation and taxes. The master variable is capital expenditure, not revenue.

The business is simple, defensive, and structurally protected: a legal monopoly franchise with statutory barriers to entry, recession- and inflation-resilient demand, and — for the first time in two decades — a genuine load-growth tailwind from data centers (Exelon’s pipeline has roughly doubled to ~18 GW). Management guides 5–7% operating-EPS growth “near the top end” through 2029 on a $41.7B four-year capital plan that is ~80% weighted to transmission, and pays a safe, growing dividend (~$1.58/share in 2025, ~58% payout, ~3.6% yield). FY2025 delivered revenue of $24.3B, GAAP net income of $2.77B, and operating EPS in the ~$2.65 range, with 2026 guidance of $2.81–$2.91.

The problem is quality, and it lives in Illinois. Exelon earns the lowest consolidated ROE among large-cap regulated peers (~9.0% in 2024, ~9.6% in 2025) and the lowest single-utility allowed ROE in the group: ComEd’s Illinois grid plan was rejected by the Illinois Commerce Commission in December 2023, then refiled, and now carries an 8.905% allowed ROE on a regulator-imposed 50% equity ratio — terms ComEd is appealing. The affordability backlash that has dogged Illinois (where bills are rising on top of a >1,000% PJM capacity-price spike, against the backdrop of a 2020 ComEd bribery scandal) has now reached a second jurisdiction: in April 2026 PECO withdrew its Pennsylvania rate cases rather than press for increases in a hostile political climate, deferring distribution capital. Exelon’s response — cutting $350M of 2027 O&M, reprioritizing distribution capex into transmission, and leaning on its diversification — is competent and shareholder-aware, but it underscores that the company’s growth is gated by six commissions plus FERC, and its two most consequential state regulators (Illinois, now Pennsylvania) are the least friendly.

The capital-allocation record is the cleanest part of the story: a well-designed comp plan paid on operating EPS, operating ROE, reliability and relative TSR (with PSU payouts that have genuinely missed target); a disciplined, growing dividend; no buybacks (correct for a heavy-build utility); and a credible balance-sheet plan targeting ~14% FFO/debt. The cost is ~1%/year structural dilution from the ATM equity program that funds the capex deficit (shares 979M in 2021 → 1,022M in 2025), and a balance sheet that does not self-fund — FY2025 operating cash flow of $6.25B against ~$8.5B of investing outflows, bridged by net debt and equity.

Valuation is the crux. On an absolute basis EXC is not cheap — it sits at the 88th percentile of its own ten-year valuation range (P/B 93rd, P/S 93rd percentile). On a relative basis it is the cheapest large-cap regulated utility, ~16x forward operating EPS versus ~18–21x for higher-quality peers — and that discount is roughly fair, a direct read on its inferior earned ROE and Illinois regulatory risk. The embedded expectations underwrite the base case: steady 5–7% EPS growth, no ComEd disaster, no affordability contagion. The market is neither pricing the bull (a ComEd appeal win + earned-ROE convergence to 10%) nor the bear (a structural ROE/equity-cap reset spreading from Pennsylvania). This memo lays out the evidence, the embedded expectations, and the falsification tests for both sides; it takes no position and sets no price target.

2. Business Overview

What Exelon does. Exelon is a utility holding company whose entire economic substance is the ownership of six rate-regulated local-monopoly utilities that deliver electricity and natural gas. It builds, owns, operates and maintains the poles, wires, substations, transformers, gas mains and meters that connect generation to ~10.7 million customer accounts — and it earns a regulator-set return on the capital invested in that infrastructure. It does not generate electricity, does not own competitive power plants, and (post-spin) takes essentially no commodity-price or merchant-market risk: fuel and purchased-power costs are passed through to customers under regulated supply mechanisms. This is the lowest-risk, lowest-volatility model in the utility sector — pure wires, no generation.

The six operating utilities (FY2025 context):

• ComEd (Commonwealth Edison) — northern Illinois incl. Chicago; ~4M+ electric customers; Exelon’s largest single utility by rate base; regulated by the Illinois Commerce Commission (ICC). Electric delivery only (no gas).
• PECO — southeastern Pennsylvania incl. Philadelphia; ~1.7M electric + ~0.5M gas customers; Pennsylvania PUC. Historically Exelon’s best-run, most constructive jurisdiction.
• BGE (Baltimore Gas & Electric) — central Maryland; ~1.3M electric + ~0.7M gas; Maryland PSC.
• Pepco (Potomac Electric Power) — Washington DC + suburban Maryland (Montgomery/Prince George’s); electric only; DC PSC + Maryland PSC.
• Delmarva Power (DPL) — Delaware + parts of Maryland; electric + gas; Delaware PSC + Maryland PSC.
• Atlantic City Electric (ACE) — southern New Jersey; electric only; New Jersey BPU.

Pepco, DPL and ACE are held under the Pepco Holdings intermediate holding company (acquired by Exelon in 2016). All six utilities operate within the PJM Interconnection, the regional transmission organization spanning the Mid-Atlantic and parts of the Midwest.

How it makes money — the regulated formula. A regulated utility’s revenue requirement is built up as: (rate base × allowed return) + operating expenses + depreciation + taxes, where the “allowed return” blends the cost of debt with an allowed ROE applied to the equity portion of rate base. “Rate base” is the depreciated capital prudently invested to serve customers; Exelon’s net property, plant & equipment of ~$84.3B (gross ~$104.4B) at FY2025 is the best public proxy. Earnings grow primarily by growing rate base — building approved wires — and the regulatory lag between spending and recovering that capital is shortened by riders, trackers, formula rates, and multi-year rate plans. For transmission, rates are set by FERC under formula mechanisms with annual true-ups and ~10.5%+ ROEs; for distribution, rates are set by each state commission through periodic rate cases or multi-year plans. The single most important driver of Exelon’s value is therefore its capital plan and the regulated return it earns on it — not sales volume.

Revenue composition. FY2025 revenue was $24.26B (up from $23.03B in 2024 and $21.73B in 2023). A large portion of reported revenue is pass-through purchased electricity and gas (FY2025 cost of sales ~$13.8B) on which Exelon earns no margin — these are commodity costs collected from customers and remitted to suppliers. The economically meaningful line is delivery (distribution + transmission) margin, which is what the regulated return is set on. Revenue is almost entirely recurring: monopoly delivery service to a stable, weather-sensitive customer base, billed monthly, with decoupling/true-up mechanisms in several jurisdictions that stabilize revenue against volume swings. Segment reporting is organized by operating utility (ComEd, PECO, BGE, Pepco Holdings/PHI), each a regulated reportable segment.

Customer and load mix. ~10 million electric accounts and ~1.9 million gas accounts; a residential-heavy, recession-resilient base across dense urban/suburban Mid-Atlantic and Chicago territories. The forward inflection is large-load / data-center demand: after two decades of flat-to-declining load, Exelon now projects ~1.3% annual load growth through 2028, driven by a data-center interconnection pipeline that has roughly doubled to ~18 GW (with ~45% secured via FERC-approved Transmission Security Agreements). Critically, as a wires-only company Exelon earns nothing on the power a data center consumes — only on the rate base it builds to serve that load. That is genuine and durable incremental rate base, but it is not an energy windfall.

Verdict. A pure-play (~100% regulated) monopoly-franchise T&D utility — the simplest, lowest-risk, lowest-volatility model in the sector. Earnings are governed by rate base × allowed ROE, cash flows are contractual in character, and the upside is gated by capex execution and regulators rather than by competitive markets. The business is easy to understand and structurally protected; the entire investment debate is about the quality of the regulatory returns on the build, not about competitive dynamism.

3. Industry Dynamics

Structure: legally protected local monopolies. U.S. regulated electric and gas utilities are the textbook government-protected industry. Within a service territory there is exactly one wires provider; entry is barred by certificate-of-convenience-and-necessity regimes and by the prohibitive economics of duplicating a grid. In exchange for the monopoly, the utility accepts cost-of-service regulation: returns are capped at an allowed ROE, and rate increases require commission approval. Market share is therefore ~100% and perfectly stable by law — but a regulator stands permanently between the moat and its economic rent, and that regulator’s job is explicitly to prevent the monopolist from earning more than its allowed return. This is the defining feature of the industry: the barrier to entry is absolute, but the rent is capped and politically contingent.

The value chain. Generation → Transmission → Distribution → Retail. Post-spin, Exelon occupies only the Transmission and Distribution middle of the chain — the regulated, non-commodity links. Within that, FERC-regulated transmission is the most attractive bucket: it earns formula-based rates with annual true-ups (minimal regulatory lag), market-tested ROEs (~10.5% base plus incentive adders), and escapes the political haircuts that state commissions impose on distribution. State-regulated distribution is lower-quality: subject to periodic rate cases, regulatory lag, disallowances, and direct affordability politics. Exelon’s strategic tilt of ~80% of its capital plan toward transmission is therefore a deliberate routing of the marginal growth dollar through its best regulator (FERC) and away from its worst (the ICC).

Marathon capital-cycle lens — the rational-regulated exception. A naive supply-side read would flag a utility raising capex, issuing growth equity, and extrapolating demand as a late-cycle warning. But the capital cycle does not operate normally where policymakers protect and regulators pre-approve returns — an explicit “breakdown” condition in the Marathon framework. Utility capex enters rate base at a quasi-guaranteed allowed return before it is spent, and competing supply is gated by interconnection queues, not free-entry market signals. The classic risk here is under-build (reliability shortfall), not over-build/return destruction. The inverse risk — and the one that is live for Exelon — is that over-earning invites political clawback: when bills rise, regulators and legislators reclaim the rent, which is precisely the Illinois and now Pennsylvania dynamic. The asset-growth anomaly still bites equity holders through dilution: heavy capex part-funded by equity creates per-share value only if incremental allowed ROE (~9–9.6% on distribution) exceeds the cost of equity (~9–10%) — a thin, sometimes negative spread on the base business, clearer only on the FERC-transmission slice.

Demand backdrop — the load-growth supercycle. The structural news for the whole sector is the first real load-growth inflection in twenty years, driven by data centers, electrification and reshoring. In PJM specifically, the supply-demand imbalance has become acute: PJM capacity-auction clearing prices spiked from $28.92/MW-day to $329.17/MW-day (>1,000%), reflecting tightening reserve margins as load rises and generation retires. This is a double-edged structural fact for Exelon. On the upside, it justifies a wave of transmission investment (rate base) and a doubling of the data-center pipeline. On the downside, those capacity costs flow through to customer bills as pure pass-through commodity cost — inflating bills, fueling the affordability backlash, and making distribution rate cases politically toxic exactly when Exelon needs them.

Regulatory landscape — jurisdiction by jurisdiction (the core of EXC’s quality). Allowed distribution ROEs from Exelon’s 2025 rate-case disclosures:

• Illinois / ComEd — worst and most contested. CEJA (2021) replaced ComEd’s prior formula-rate mechanism with multi-year “Grid Plans.” The ICC rejected ComEd’s original 2024–2027 Grid Plan (14-Dec-2023), cut the revenue requirement, imposed a 50% equity ratio (vs. the ~53–54% utilities typically request), and denied a return on the pension asset. After rehearing and a refiled Revised Grid Plan (approved 19-Dec-2024, ~$1.045B cumulative increase), the allowed ROE landed at 8.905% — the lowest in Exelon’s portfolio and among the lowest for any large-cap utility. ComEd is appealing the ROE, equity ratio and pension treatment. The next 2028–2031 Grid Plan was filed 16-Jan-2026, with an ICC order due 15-Dec-2026 — the single most important regulatory catalyst on the calendar.
• Maryland / BGE, Pepco-MD, Delmarva-MD — allowed ROEs ~9.45–9.60%; the Maryland PSC has turned tougher, and a Pepco-Maryland case is pending (requesting up to 10.50%; order ~Aug-2026). Maryland is mid-pack and watchful.
• DC / Pepco — ~9.50% (Nov-2024). New Jersey / ACE — ~9.60%. Delaware / DPL — ~9.60%, with a pending request up to 10.50% (~2027). Pennsylvania / PECO — historically settled via constructive “black-box” settlements (no stated ROE), Exelon’s best jurisdiction — until the April-2026 affordability retreat.
• Blended allowed ROE ~9.4–9.6%, dragged down by ComEd. Earned consolidated ROE was 9.6% (2025) and 9.0% (2024) — at or below allowed, and the lowest among large-cap peers — the clearest financial signature of below-average regulatory quality (ComEd’s 8.905%/50%-equity terms + holdco costs + regulatory lag).

Affordability and political risk — now the dominant industry theme. Customer bills are rising on two fronts: the capex Exelon is recovering, and the PJM capacity-price pass-through. The result is a genuine political revolt — the ICC approved a ~$606M ComEd delivery increase (~+$10.60/month) and consumer advocates warn of much larger total-bill increases; Maryland passed a Utility Relief Act; Pennsylvania’s governor issued a “justifiable returns” letter. Illinois carries unique baggage: the 2020 ComEd bribery deferred-prosecution agreement, the conviction of former ComEd CEO Anne Pramaggiore, and the Michael Madigan trial — a history that makes Illinois politics structurally hostile to ComEd rate increases. The mitigant is that large-load tariffs and Transmission Security Agreements increasingly shift interconnection and capacity costs onto data centers rather than residential ratepayers, defusing part of the backlash — but also conditioning the rate-base growth on those agreements holding.

Verdict. T&D is a structurally good — not great — industry. It is a protected monopoly, recession- and inflation-resilient, capex-rewarded, and now blessed with a real load-growth tailwind. But returns are capped, capital-hungry, and politically exposed the moment bills rise — and Exelon’s footprint concentrates exactly the two jurisdictions (Illinois, Pennsylvania) where that exposure is most acute right now. The industry is attractive; Exelon’s slice of it is more politically contested than the single-state champions (Southern’s Alabama/Georgia, NextEra’s Florida).

4. Competitive Position

The moat — name it precisely. In Greenwald’s taxonomy, Exelon’s competitive advantage is a regulated-monopoly franchise: a state-granted exclusive service territory (demand-side captivity by law — customers cannot choose another wires provider), reinforced by economies of scale in a fixed network with enormous fixed costs and near-zero marginal cost of an additional connection, and by regulatory-compact incumbency (decades of constructive relationships, qualified rate base, and the institutional knowledge to navigate six commissions plus FERC). It is not a brand moat, not a network-effects moat in the tech sense, and not a technology moat. The barrier to entry is statutory, not competitive — which makes it absolute and makes the regulator, not a rival, the entity that captures the rent.

Is the moat differentiated within the peer set? No. Every regulated utility has the same legal monopoly. The question is not whether Exelon has a moat — it does, an unassailable one — but whether it is a better-than-average operator of that moat. On the evidence, it is below average. The financial signature is the earned ROE: ~9.0% (2024) / ~9.6% (2025), the lowest among large-cap regulated peers (AEP, DUK, D, SO all earn higher), and a consolidated ROIC of ~5.7% — below a ~6–7% cost of capital. That ROIC-below-WACC reading is partly structural to all utilities (the allowed ROE applies only to the equity layer; the debt-heavy consolidated base and CWIP/AFUDC dilute ROIC by design), but Exelon’s gap is the widest in the cohort because its most important utility, ComEd, is saddled with an 8.905% allowed ROE on a 50% equity ratio. A genuine Greenwald moat (sustained ROIC well above WACC) does not exist here — and by regulatory design cannot — but even on the relative metric utilities are judged by (earned vs. allowed ROE, allowed-ROE level, regulatory constructiveness), Exelon ranks at the bottom of the large-caps.

Direct comparison with key competitors. Exelon’s relevant comparables are the other large-cap pure-ish regulated utilities — its FactorsToday nearest factor-neighbors are DUK (0.97), SO (0.97), FE, CMS, EVRG, XEL, AEE, WEC, AEP, DTE, PPL, ED — essentially the entire large-cap regulated complex.

• vs. AEP (peer coverage, Jun-2026): AEP grows rate base ~11% (vs. EXC ~7.9%), earns a higher ROE, and trades ~20.5x forward operating EPS. AEP is the higher-growth, higher-quality, more expensive peer. EXC is the cheaper, slower, lower-quality cousin.
• vs. DUK / SO: both earn higher ROEs in more constructive single- or two-state regimes (the Carolinas; Alabama/Georgia), trade ~18–19x, and carry no ComEd-style overhang. EXC’s discount to them is the “Illinois discount.”
• vs. single-state champions (NEE/FPL): not comparable on quality — Florida’s regulatory construct is the gold standard; EXC’s six-commission, two-hostile-jurisdiction footprint is structurally messier.

The one genuine relative edge — transmission and FERC mix. Where Exelon does differentiate favorably is the ~80% transmission weighting of its capital plan and a transmission rate base growing ~16%/year through 2029. Transmission is FERC-regulated — formula rates, ~10.5%+ ROEs, low lag — so Exelon is deliberately growing its highest-quality earnings stream fastest while its lowest-quality stream (Illinois distribution) is throttled by the ICC. This is the single best structural decision in the story and the reason the bull case is not hollow: the marginal growth dollar earns a better, more certain return than the consolidated average implies. It does not fix the ComEd problem, but it routes around it.

Switching costs / customer captivity. Total and legal — customers cannot switch wires providers. But this captivity accrues its rent to the regulator’s discretion, not to Exelon’s pricing power. The “pricing power” of a utility is the allowed ROE, and Exelon’s is the lowest in the group.

Verdict. Exelon has the generic, unassailable regulated-monopoly moat that every utility has, but not a differentiated one — and within the peer set it is a below-average-quality operator, impaired by its single most important jurisdiction (Illinois). The offsets are real but partial: an ~80% FERC-transmission tilt that grows its best earnings stream fastest, an ~18 GW data-center pipeline, ~7.9% rate-base growth, and six-state + FERC diversification that lets it reprioritize capital when one jurisdiction turns hostile (as it just did with PECO). Net: a durable franchise wrapped around below-average regulatory quality — own it for the discount and the transmission/load-growth optionality, not for any franchise superiority.

5. Growth History and Forward Opportunities

Historical growth — read post-spin only. Exelon’s pre-2022 financials are dominated by the now-departed Constellation generation/commodity business (FY2020 revenue $33B with a 50%+ EBITDA-margin distortion from commodity accounting) and are not comparable to the modern company. The clean series begins with FY2023 as the first fully clean post-spin year. On that basis: revenue grew $21.7B (2023) → $23.0B (2024) → $24.3B (2025); GAAP net income $2.33B → $2.46B → $2.77B; GAAP EPS $2.33 → $2.45 → $2.71; operating EPS (the metric management guides and pays on, which post-spin runs very close to GAAP) grew at roughly the mid-single-digit rate the company targets. This is almost entirely organic rate-base growth — earning an allowed return on a continuously growing pile of regulated capital (net PP&E $78.2B in 2024 → $84.3B in 2025, +7.8%) — not acquisition-driven. There has been no major M&A since the 2016 Pepco Holdings deal; goodwill is a static $6.63B.

The forward build — $41.7B over four years. At Q1-2026 management presented a revised $41.7B 2026–2029 capital plan (raised from a prior ~$38B), funding ~7.9% annualized rate-base growth. The composition is the story:

• ~80% transmission-weighted. Transmission rate base is guided to grow ~16%/year through 2029 — far faster than distribution — routing the marginal dollar through FERC formula rates (higher ROE, lower lag). The Q1-2026 rebalance explicitly cut $1.1B of PECO and BGE distribution and added $1.5B of transmission, “maintaining” the 7.9% rate-base CAGR despite the affordability-driven distribution pullback. This is the diversification thesis working in real time.
• Data-center / large-load. The interconnection pipeline roughly doubled to ~18 GW, with ~45% secured via FERC-approved Transmission Security Agreements (TSAs) that have posted ~$1B of collateral — shifting interconnection cost to the data centers and de-risking the rate base. Management cites $12–17B of upside beyond the plan (not including recent competitive-transmission bids or potential solar/storage), driven by reliability needs, coal retirements (e.g., Brandon Shores in Maryland requiring transmission), and load growth.
• Competitive transmission. Exelon is bidding into RTO competitive-transmission windows — ~$1.9B of MISO Tranche 2.1 projects (with partner Invenergy) submitted Feb-2026, with more bids expected — a genuine, if lumpy, source of incremental rate base beyond its native footprint.

The growth guidance. Management guides operating-EPS growth of 5–7% (2025–2029), “near the top end” of the range, and reaffirmed 2026 operating EPS of $2.81–$2.91 (with a stated goal of midpoint-or-better) even after the PECO withdrawal and capex rebalance. The earnings algorithm is: ~7.9% rate-base growth, less ~1%/year dilution drag, plus earned-ROE improvement (closing regulatory lag) and O&M discipline (≤2% growth, $350M of 2027 cuts), nets to ~6–7% EPS growth. The combination of mid-single-digit EPS growth and a ~3.6% yield is a ~9–10% total-return algorithm if the multiple holds.

The honest deduction — the growth is gated by regulators and just took a hit. The PECO withdrawal is the first concrete evidence that the affordability backlash can force Exelon to defer rate base, not merely earn a lower return on it. Management spun the rebalance as agility — and it is a credit to the diversified portfolio that it could move $1.5B into transmission to hold the 7.9% — but the underlying fact is that one of its two best jurisdictions became un-fileable for a year. If Pennsylvania’s “justifiable returns” regime hardens, or Maryland follows, the “maintain 7.9%” arithmetic gets harder to sustain.

Verdict. Mostly high-quality, regulator-gated growth. It is organic, regulated, pre-approved into rate base, increasingly demand-side-protected (TSAs, large-load tariffs), and tilted toward the highest-return, lowest-lag bucket (FERC transmission). The ~7.9% rate-base CAGR is above the peer median, and the data-center optionality is real. The two deductions: (1) ~1%/year dilution clips the per-share rate, and (2) the distribution leg of growth is hostage to affordability politics in Illinois and now Pennsylvania — a risk that just materialized. This is solid, defensible growth, but not the de-risked, take-or-pay-contracted growth profile of an AEP, and the regulatory gate is heavier than the headline 7.9% implies.

6. Financial Quality

Revenue and margin. FY2025 revenue $24.26B (+5.3% YoY), but recall ~$13.8B is pass-through commodity cost on which no margin is earned; the economically meaningful delivery margin sits inside the $10.4B gross profit (42.9% gross margin) and $5.15B operating income (21.2% operating margin). Margins are a regulatory artifact of a capital-intensive, depreciation-heavy cost structure — “margin” here is essentially the allowed return on rate base plus pass-throughs, not a competitive achievement — so the trend matters more than the level: operating margin expanded 18.5% (2023) → 18.7% (2024) → 21.2% (2025), and EBITDA grew $6.8B → $7.2B → $8.19B (33.8% margin), reflecting rate-base growth and new rates flowing through. This is the expected “economics improve modestly with rate-base scale” pattern of a constructive build — gated, again, by the allowed return.

Earnings quality — clean, with FY2023 as the anchor. Post-spin, Exelon’s reported and operating earnings are unusually low-noise: operating EPS ≈ GAAP EPS, with adjustments limited to modest severance, mark-to-market, and small impairments. There is no large recurring one-time item distorting the run-rate (unlike, say, AEP’s transmission true-ups or JPM’s Visa gain). The ~$2.65–$2.77 operating-EPS range and the 5–7% growth target are therefore reliable run-rate anchors. The one caveat: the 2021 and earlier figures are generation-inflated and must be discarded; use 2023+ only.

ROE / ROIC — the quality tell. Consolidated ROE rose 8.9% (2023) → 9.0% (2024) → 9.6% (2025) — improving, but still the lowest among large-cap peers, and only at-or-near allowed. ROIC ~5.1% → 5.6% → 5.7% — below cost of capital, structurally (debt-heavy base, CWIP/AFUDC) but more so than peers because of ComEd’s terms. The improving trend is real and matters (it is the earned-ROE-convergence leg of the growth algorithm), but the absolute level confirms the below-average-quality verdict. Management guides a consolidated 9–10% earned ROE for 2026.

Cash flow — negative FCF by design. This is the structurally important point. FY2025 operating cash flow was $6.25B, against investing outflows of ~$8.5B (overwhelmingly capex) — so free cash flow after capex was deeply negative (~−$2.3B). (Note: ROIC’s data feed labels OCF as “free cash flow,” which is misleading for a heavy-build utility — true post-capex FCF is negative every year.) The gap is bridged by net debt issuance (+$3.5B in 2025) and equity (+$0.69B via the ATM). Dividends paid were $1.62B. This is normal and expected for a regulated utility in a heavy-build cycle — the build is the value creation, pre-approved into rate base — but it quantifies the structural dependence on continuous access to debt and equity markets. Never apply a P/FCF multiple to this business; the FCF analogs are rate-base growth, FFO/debt, and dividend coverage.

Balance sheet — leveraged, as utilities are, with a watch item. FY2025: total debt $50.1B, net debt $49.5B, equity $28.8B, total assets $116.6B. Headline net debt/EBITDA ~6.0x looks high but is normal for a T&D holdco (the relevant credit metric is FFO/debt, which management targets at ~14% at both Moody’s and S&P — the rating-agency threshold). Interest coverage is adequate but not generous: EBITDA/interest ~3.85x, operating income/interest ~2.42x, and interest expense is rising ($1.73B → $1.91B → $2.13B over three years) as the debt stack grows and reprices — a structural headwind the rate-base growth must outrun. Book value per share ~$28.2. The balance sheet is manageable but not a fortress: PECO/Pepco Holdings was already on negative outlook / review for downgrade at S&P following the Pennsylvania developments (per management on the Q1-2026 call), and the whole plan is a multi-year bet on holding ~14% FFO/debt while funding a ~$2–3B annual cash deficit. Management is using junior-subordinated hybrids and convertibles ($1.0B hybrid Feb-2025, $1.0B convertible Dec-2025) as equity-credit tools to soften common dilution — sensible, but a sign the balance sheet is working hard.

Dilution. Shares outstanding grew 979M (2021) → 994M → 999M → 1,005M → 1,022M (2025) — ~1%/year structural dilution from the ATM/forward-equity program that funds the capex deficit. Management has framed forward equity needs as ~$3.4B through 2029 (~40% of the incremental capital plan, <2% of market cap annually), with 2026’s ~$850M and part of 2027 already priced via forward contracts. This is disciplined relative to the build, but it is a real, recurring drag on per-share growth.

Verdict. Economics improve modestly with scale, exactly as a constructive regulated build should — but from the lowest base in the peer group, and entirely dependent on the kindness of regulators and capital markets. Earnings quality is clean and the run-rate is reliable; margins, EBITDA and ROE are all trending up; the dividend is well-covered. The debits are structural and unavoidable: negative FCF, rising interest expense, ~1%/year dilution, a leveraged balance sheet running to a ~14% FFO/debt guardrail, and the lowest earned ROE in the cohort. This is a financially sound utility, not a financially strong one.

7. Capital Allocation

The cleanest part of the thesis. Exelon’s capital allocation and incentive design are genuinely good — arguably the strongest qualitative element of the investment case, and a meaningful offset to the regulatory quality problem.

Compensation and incentive alignment. The 2025 proxy structure maps directly to shareholder-value drivers, and payouts genuinely vary:

• Annual incentive (AIP): 60% operating EPS, 15% SAIDI / 15% SAIFI reliability, 10% customer satisfaction. Earnings-gated, operations-weighted — exactly right for a utility.
• Long-term incentive (LTIP): 67% performance shares / 33% RSUs, with PSU metrics split across Operating ROE, Operating EPS, and a CFO/Debt credit metric, all under a 3-year relative-TSR modifier versus the UTY utility index.
• The metrics bind. The 2022–2024 PSU cycle paid only 83.76% (below target), while 2024/2025 AIP paid ~134–137% — demonstrating real pay-for-performance variance, not a rubber-stamp. Crucially, there is no “rate-base growth” or “capital deployed” metric anywhere in the plan — which structurally removes the empire-building / over-build incentive that plagues utilities paid on asset growth. CEO Calvin Butler’s 2025 total comp was ~$15.6M, ~70% at-risk equity; CFO Jeanne Jones ~$3.3M target.

Dividend — safe and growing. The dividend was reset after the 2022 spin (the pre-spin payout reflected the combined company) and has grown steadily: $1.34 (2022) → $1.44 → $1.52 → ~$1.58 (2025), ~5–6%/year, on a ~58% payout of operating EPS against a stated ~60% target policy and a yield of ~3.6%. Coverage is comfortable, the growth tracks EPS, and the policy is conservative. This is a reliable, growing income stream — a core part of the total-return case and a source of downside support.

No buybacks — correct. A heavy-build regulated utility should be a structural net issuer of equity to fund rate base, not a repurchaser; Exelon does no buybacks, which is the right call. The flip side is the ~1%/year dilution discussed in the Financial Quality section.

Funding discipline. Through 2029 management plans to fund the ~$47B+ total capital program (including maintenance) with ~$21.8B internal cash, ~$13.1B utility debt, ~$3.4B holdco debt, and ~$3.4B equity — with the equity content held to ~40% of the incremental plan and <2% of market cap annually, and a large share already forward-priced. The use of hybrids/convertibles to maximize equity credit while minimizing common dilution is a sophisticated, shareholder-aware approach. The balance-sheet target (~14% FFO/debt, “above downgrade thresholds”) is explicit and credible.

M&A. None of note since Pepco Holdings (2016); goodwill is static at $6.63B; no acquisition overhang. The major strategic capital-allocation act of the era — the 2022 Constellation spin — was value-clarifying (it separated a volatile commodity business from a stable regulated one, and CEG has since substantially outperformed, but the spin itself was the right structural call for a regulated-focus thesis).

Insider activity — no signal. Across the trailing-5-year Form 4 corpus there are zero open-market purchases (code P) — every insider filing is a routine grant (code A), option/RSU conversion (M), or tax withholding (F). For a regulated utility this is the expected pattern and carries near-zero signal, but it also means there is no insider-conviction tell to lean on in either direction.

Verdict. Management has allocated capital intelligently. A well-designed comp plan paid on per-share earnings, ROE, credit and relative TSR (with no rate-base-growth metric and genuine downside payout variance); a safe, growing, conservatively-covered dividend; no value-destructive buybacks or M&A; a disciplined, equity-credit-conscious funding stack; and a value-clarifying spin. The one honest caveat is the ~1%/year dilution inherent in funding a build that the business cannot self-finance — acceptable only to the extent the incremental capital earns its allowed return, which loops back to the regulatory-quality problem. Good stewards of a structurally capital-hungry, regulator-constrained business.

8. Changes and Headwinds — Last Two Years

Strategic / capital-plan changes.

• Capex plan raised then rebalanced. The 2025–2028 plan (~$38B) was lifted to a $41.7B 2026–2029 plan, ~80% transmission-weighted, holding ~7.9% rate-base growth. At Q1-2026 management explicitly cut $1.1B of PECO/BGE distribution capex and added $1.5B of transmission in response to affordability pressure — the diversification thesis in action.
• Data-center pipeline doubled to ~18 GW, with ~45% under FERC-approved Transmission Security Agreements (~$1B collateral posted), and ~$12–17B of upside flagged beyond the plan.
• Competitive-transmission entry: ~$1.9B of MISO Tranche 2.1 bids (with Invenergy) submitted Feb-2026, with further PJM/ISO bids expected — a new, lumpy growth avenue.

Regulatory developments (the headwinds).

• Illinois / ComEd: the ICC’s Dec-2023 rejection of the Grid Plan, the refiled plan approved Dec-2024 at 8.905% ROE / 50% equity, ComEd’s pending appeal, and the next 2028–2031 Grid Plan filed Jan-2026 (order due 15-Dec-2026). This is the dominant medium-term regulatory swing factor.
• Pennsylvania / PECO — the new crack. In April 2026 PECO withdrew its electric and gas rate cases citing affordability, after Governor Shapiro’s letter demanding “cost-effective capital, transparency, and justifiable returns.” Management deferred distribution capital and cited stakeholder feedback. A leadership change followed (PECO CEO moved to an advisory role; COO Michael Innocenzo stepped in as interim). This is a self-inflicted (defensive) deferral that signals Pennsylvania has joined Illinois as a politically hostile jurisdiction.
• Maryland passed a Utility Relief Act (awaiting signature); a Pepco-Maryland rate case is pending (order ~Aug-2026). HB 1561 (utility-owned backstop generation/storage) was advocated by Exelon but did not establish the path it sought.
• PJM capacity crisis: clearing prices spiked >1,000% ($28.92 → $329.17/MW-day), inflating customer bills and intensifying the affordability backlash across all jurisdictions.

Operational / cost actions. Management announced $350M of incremental 2027 O&M savings (tied to deferred work), a target of ≤2% adjusted O&M growth through 2029, AI/technology-driven efficiency, reduced contractor use, managed hiring, and a voluntary separation program later in 2026 — a credible, shareholder-aware cost response to the affordability/rate-case pressure.

Leadership / board. CEO Calvin Butler (also President) is settled; CFO Jeanne Jones; new independent director David DeWalt joined Mar-2025. The PECO interim-CEO change is the notable operating shuffle.

Financing. A steady cadence of debt/hybrid/convertible issuance to fund the capex deficit ($1.0B hybrid Feb-2025; $1.0B convertible Dec-2025; $775M senior notes Feb-2026; ~43% of 2026 debt needs completed by Q1), with PECO/Pepco-Holdings on negative outlook / review for downgrade at S&P.

Verdict. The changes net modestly negative for the thesis. The capex raise, transmission tilt, data-center pipeline and cost discipline are genuine positives that strengthen the growth and quality story. But they are outweighed in importance by the regulatory deterioration: an unresolved, below-average ComEd outcome under appeal, and — newly — the spread of affordability hostility into Pennsylvania, which forced an actual capital deferral. The diversified portfolio absorbed the PECO hit gracefully (a real demonstration of resilience), but the direction of regulatory travel is the wrong way, and it is the variable that matters most.

9. Risk Analysis

Risk summary. The dominant near-term and medium-term risks are regulatory and political, not existential — concentrated in Illinois (ComEd’s allowed ROE and the 2028–31 plan) and the spreading affordability backlash (now in Pennsylvania). Interest rates are the dominant market risk, hitting EXC twice (multiple compression of the bond proxy + financing-cost drag). Catastrophic loss risk is very low: this is a diversified, regulated monopoly with passthrough commodity risk and reliable cash flows. The risk profile is asymmetric toward the regulatory tail — the base case is dull and safe, but the left tail (a structural ROE/equity reset spreading across jurisdictions) is the scenario that would impair the thesis.

10. Valuation Discussion (Embedded Expectations)

Where the stock trades. At ~$45.81 (18-Jun-2026), ~1,022M shares, market cap ~$47–50B, net debt ~$49.5B, EV ~$95–100B. The multiples:

The two-sided valuation read — this is the whole debate.

• Absolute (own history): not cheap. EXC sits at the 88th percentile of its own ten-year valuation (P/B 93rd, P/S 93rd). The 2025–26 re-rate took it from ~$36 to ~$50 and left it near the top of its historical range. On its own history, this is a full price, not a value entry.
• Relative (vs. peers): the cheapest large-cap regulated utility. At ~16x forward operating EPS, EXC trades at a meaningful discount to AEP (~20.5x), DUK/SO (~18–19x), and well below NEE. The discount is the “Illinois discount” — and it is deserved: EXC earns the lowest ROE in the cohort, carries the worst single-utility allowed ROE (ComEd 8.905%), and now has a Pennsylvania affordability crack. The relevant question is not whether the discount exists but whether it is too large, about right, or too small. On the evidence, it is roughly right — the quality gap is real and the discount fairly compensates for it.

Embedded-expectations analysis — what the current price underwrites. At ~16x forward operating EPS with ~6% EPS growth and a 3.6% yield, the market is pricing the base case and little else: steady 5–7% operating-EPS growth, no ComEd appeal disaster and no appeal windfall, the PECO affordability issue contained to a one-year deferral (not a structural ROE reset), FFO/debt holding ~14% with no downgrade cascade, and the multiple roughly stable. In other words, the price is consistent with EXC continuing to be exactly what it is — a sound, slow, below-average-quality regulated utility executing a transmission-tilted build. The market is not pricing the bull (ComEd winning a materially better ROE/equity ratio + earned ROE converging to 10% → multiple re-rates toward peers) and not pricing the bear (a structural ROE/equity-cap reset spreading from Pennsylvania to Maryland → EPS growth falls below 5% and the discount widens).

Scenario sketch (operating-EPS / multiple, illustrative, not a price target):

• Bear (~25% weight): PA affordability regime hardens into lower allowed ROE/equity caps, spreads to MD; EPS growth slips to ~3–4%; FFO/debt pressure forces a downgrade. Multiple de-rates toward ~13–14x. A ~15–20% drawdown scenario.
• Base (~55% weight): ~6% operating-EPS growth, ComEd appeal a modest partial win or neutral, PECO refiles in 2027, transmission/data-center growth delivers. Multiple holds ~16x. Total return ≈ yield + EPS growth ≈ 9–10%.
• Bull (~20% weight): ComEd wins a better ROE/equity ratio on appeal or in the 2028–31 plan; earned ROE converges to 10%; data-center upside ($12–17B) converts; the Illinois discount narrows toward peers. Multiple re-rates to ~18x. A ~25–30% upside scenario.

Cross-check vs. the spin sibling. Constellation (CEG) — the generation business spun out of the same company in 2022 — has dramatically outperformed EXC since the spin as merchant nuclear became an AI-power darling. That is a useful reminder that EXC deliberately kept the boring half: lower growth, lower volatility, lower returns, but also far lower risk. EXC is the defensive residual, and it is priced as such.

Verdict. Fair, not cheap — and metric-dependent. EXC is the cheapest large-cap regulated utility on forward earnings, but at the 88th percentile of its own history on book and sales; the inter-peer discount is real but deserved and roughly correctly sized. The embedded expectations are undemanding but offer little margin of safety at this level — the forward return is essentially the ~3.6% yield plus ~6% EPS growth, with the multiple priced for continuation and a live regulatory tail to the downside. The value case requires either a lower entry (where the discount over-compensates) or a regulatory inflection (ComEd appeal win) that the market is not paying for. No price target; no recommendation.

11. Variant Perception

Consensus view. Sell-side and the market hold EXC as a defensive, lower-growth, lower-quality regulated utility trading at a deserved discount — a “show-me” story on Illinois with a decent yield and a credible transmission/data-center growth hook. The recent Truist downgrade-of-price-target (to $49, Hold, May-2026) and the spring pullback capture the mood: respectable, un-exciting, priced about right, with Illinois and now Pennsylvania as the overhangs. Consensus operating-EPS growth ~5–7%; consensus sees the PECO withdrawal as a manageable deferral, not a structural break.

The strongest bull case. The discount is too wide and about to close. EXC has above-median rate-base growth (~7.9%), the fastest-growing FERC-transmission rate base in the group (~16%/yr), an ~18 GW data-center pipeline with $12–17B of upside, and 5–7% EPS growth guided near the top end — i.e., a growth profile not far below the higher-quality peers, at a ~4–5 turn lower multiple. If ComEd wins even a partial improvement on appeal or in the 2028–31 plan, and earned ROE converges toward 10%, the market re-codes EXC from “Illinois problem child” to “cheap transmission grower,” and the discount narrows toward peers — a re-rate from ~16x toward ~18x plus the underlying growth. The factor tape supports patience: low beta, positive alpha, a defensive bid that holds up in drawdowns.

The strongest bear case. The discount is too narrow given where regulation is heading. EXC earns the lowest ROE in the cohort, its largest utility is stuck at 8.905%/50% equity and is appealing (an admission the base terms are bad), and the affordability backlash that crushed ComEd’s economics has now forced an actual capital deferral in Pennsylvania — previously the good jurisdiction. If Pennsylvania institutionalizes lower “justifiable returns” and Maryland follows, EXC’s EPS growth slips below 5%, the ~14% FFO/debt guardrail gets tested, a downgrade raises the cost of the perpetual deficit funding, and the stock — at the 88th percentile of its own history — de-rates. The bear says you are paying a full own-history price for a company whose regulatory environment is structurally deteriorating.

The 3–5 assumptions that matter most:

1. ComEd’s allowed ROE / equity ratio trajectory (appeal outcome + 2028–31 Grid Plan, order Dec-2026). Bull: improves toward 9.5%+. Bear: stays ~8.9% or worse.
2. Whether Pennsylvania’s affordability regime is cyclical or structural. Bull: PECO refiles constructively in 2027. Bear: lower allowed ROE/equity caps institutionalize and spread.
3. Earned-vs-allowed ROE convergence (does consolidated ROE reach the guided 9–10% and hold?). Bull: yes, lag closes. Bear: persistent lag keeps ROE the lowest in the group.
4. Balance-sheet durability (FFO/debt holds ~14%, no downgrade cascade). Bull: holds. Bear: PA/IL pressure + rising rates force a downgrade.
5. Data-center conversion (~18 GW pipeline → rate base, $12–17B upside). Bull: TSAs convert, upside materializes. Bear: unsecured pipeline shrinks.

Factor-positioning read (the tape as evidence). FactorsToday codes EXC as a pure defensive utility: beta ~0.04 (essentially market-neutral), a dominant LowVolatility loading (~0.48) and a ~0.88–0.91 Utilities-sector loading — no momentum or growth identity. Risk-adjusted track record: y1 return +12% (a rate/yield re-rate, the same one that lifted the cohort), y5 ~+10%/yr, lifetime only ~4.5%/yr with a −62% max drawdown (the pre-spin generation era’s volatility). The recent tape is not momentum — m3 is negative (−1.7%), m6 positive — a defensive name that pulled back on the PA news, not a trend to chase and not a falling knife. Its ten nearest factor neighbors are all regulated utilities (DUK, SO, FE, CMS, EVRG, XEL, AEE, WEC, AEP, DTE) — confirming the market trades EXC as a generic low-vol bond proxy, with no drift toward the AI-power growth names (CEG, VST). The variant this supports: the +12% trailing year was an interest-rate/yield re-rate, not a re-coding of EXC as a grower — meaning the variable the market is actually trading is rates, not Illinois. That cuts both ways: it means a rate backup is the swing risk to the multiple, while the fundamental (Illinois) overhang is largely idiosyncratic and arguably under-traded by a factor crowd focused on yield.

Where I come out (feeding Claude’s Take). The bear’s regulatory-deterioration argument is the more important one right now — the PECO withdrawal is fresh, concrete evidence that the affordability backlash bites EXC’s growth, not just ComEd’s return — but it is also largely known and priced (hence the deserved discount and the 88th-percentile-but-cheapest-peer paradox). That balance is what makes EXC a HOLD: the discount is roughly fair, the downside tail is real but priced, and the upside requires a regulatory inflection the market is not paying for. The asymmetry only turns attractive at a lower entry.

12. Fact vs. Interpretation Table

13. Open Questions

1. What does ComEd’s appeal yield, and what is the 2028–2031 Grid Plan ROE/equity ratio (order due 15-Dec-2026)? This single outcome is the largest swing factor on EXC’s quality and multiple.
2. Is Pennsylvania’s “justifiable returns” stance cyclical or structural? Will PECO refile in 2027 at constructive terms, or has the allowed ROE/equity environment permanently reset lower? Does Maryland follow?
3. Does consolidated earned ROE actually converge to the guided 9–10% and hold there, or does persistent regulatory lag keep it the lowest in the cohort?
4. How much of the ~18 GW data-center pipeline converts to rate base, and on what timeline — how durable are the TSAs, and what happens to the ~55% not yet secured?
5. Does FFO/debt hold ~14% through the build, or do PA/IL pressure plus rising rates force a PECO/Pepco-Holdings downgrade that raises the cost of perpetual deficit funding?
6. What is the true normalized cost of equity vs. allowed ROE spread on the base (non-transmission) business — is the per-share value-creation spread positive after dilution, or is EXC running to stand still on distribution?
7. How much incremental competitive-transmission rate base (MISO/PJM bids) is realistically winnable, and at what returns?

14. What Must Be True

For the bull case (discount closes; re-rate toward peers):

• ComEd wins a materially better ROE and/or equity ratio on appeal or in the 2028–31 Grid Plan (e.g., ROE toward 9.5%+, equity ratio toward 52–53%).
• Consolidated earned ROE converges to ~10% and holds, closing the gap to peers.
• Pennsylvania proves cyclical — PECO refiles constructively in 2027; affordability does not spread to Maryland as a structural ROE reset.
• The transmission/data-center build (~7.9% rate base, ~16% transmission, $12–17B upside) delivers on schedule with TSAs converting.
• Falsification test: if, by the 15-Dec-2026 ICC order plus the 2027 PECO refiling, ComEd’s allowed ROE is not improved and Pennsylvania’s allowed ROE/equity terms come in structurally lower, the bull thesis is broken — the discount is not closing, it is justified and possibly widening.

For the bear case (deterioration; de-rate from a full own-history price):

• Pennsylvania institutionalizes lower allowed ROE/equity caps, the stance spreads to Maryland, and EXC’s EPS growth slips below 5%.
• FFO/debt breaches ~14% and a downgrade lands, raising the cost of the multi-year deficit funding.
• ComEd’s appeal fails and the 2028–31 plan is no better or worse.
• Falsification test: if, over the next four to six quarters, EXC reaffirms 5–7% EPS growth near the top end, holds FFO/debt ~14% with no downgrade, ComEd’s appeal/plan delivers a partial improvement, and PECO refiles constructively — the bear’s “structural deterioration” thesis is refuted, and EXC is simply a sound utility at a deserved-but-stable discount.

15. Source Appendix

(Consolidated in the separate Source Appendix deliverable; primary sources below.)

• Exelon Corporation FY2025 Form 10-K and FY2021–2024 10-Ks; quarterly 10-Qs (SEC EDGAR, CIK 0001109357).
• Exelon Q1-2026 earnings call transcript, 6-May-2026 (ROIC.ai / Exelon IR) — PECO withdrawal, $41.7B capex plan, 7.9% rate-base / 16% transmission growth, ~18 GW data-center pipeline, $350M O&M cuts, ~14% FFO/debt target, 2026 guidance $2.81–$2.91.
• Exelon DEF 14A proxy statements (2024–2025) — compensation structure, AIP/LTIP metrics, PSU payout history.
• Exelon 8-K material-event filings, 2022–2026 (Constellation spin, rate-case outcomes, financings, exec changes).
• Illinois Commerce Commission Grid Plan / multi-year rate plan orders (Dkt. 23-0055 and related), Dec-2023 / Dec-2024.
• ROIC.ai — income statement, balance sheet, cash flow, profitability/credit/valuation ratios, enterprise value (FY2020–2025, TTM).
• AZI valuation_index (own-history percentile ranks) and 5-year price CSV.
• FactorsToday — stock-info, leaderboard, loadings, related-stocks (factor positioning).
• AZI news feed (Truist PT cut to $49; “AI power surge sparks political revolt against utility profits”).
• Prior peer coverage cross-read: AEP (14-Jun-2026), DUK (14-Jun-2026), D (19-Jun-2026), SO (13-Jun-2026), NEE (11-Jun-2026).

This article’s body takes no position and sets no price target. The only position-taking content is the clearly-labeled Claude's Take block, which is the author’s own opinion and general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire — Exelon Corporation (NASDAQ: EXC)

Supplemental to the research memo. Grounded in the research log; Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The dominant investor questions cluster on Illinois: Will ComEd’s 8.905% allowed ROE improve on appeal or in the 2028–31 Grid Plan? and Is the earned-vs-allowed ROE gap closing? Newer questions (post-Q1-2026) focus on Pennsylvania: Is the PECO rate-case withdrawal a one-year timing decision or a structural reset of allowed returns? and Does the governor’s “justifiable returns” letter point to a lower ROE/equity cap? Cross-cutting: Can EXC hold 5–7% EPS growth and ~14% FFO/debt while funding a multi-year cash deficit with rising-rate debt and ~1%/yr equity dilution? and How real is the ~18 GW data-center pipeline, and how much converts to rate base? (Fact: these are the live debate topics in the Q1-2026 Q&A — Wells Fargo, Wolfe, Barclays, Jefferies analysts.)

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Neither in a traditional sense — a regulated T&D utility’s earnings are not cyclical; they track rate base × allowed ROE. EXC’s earnings are in a steady upcycle of rate-base growth (~7.9%/yr), with margins/ROE improving off a post-spin trough but still the lowest in the peer group. (Interpretation.)

Driven by external environment or internal actions? Primarily internal/regulatory: the capital plan and rate-case outcomes. The one external swing is interest rates (financing cost + bond-proxy multiple) and PJM capacity prices (which inflate customer bills and stoke the affordability backlash that constrains rate cases).

How stable are revenues? Very stable — monopoly delivery to ~10.7M accounts, monthly billing, weather-normalized/decoupled in several jurisdictions, large pass-through commodity component. Volume is recession-resilient.

Outlook for products/services / market size? The “product” is regulated energy delivery; the market is the six fixed service territories. After two decades of flat load, demand is inflecting up (~1.3%/yr through 2028) on data-center/electrification growth — a genuine, durable tailwind, but one EXC monetizes only via rate base (it earns nothing on the energy itself).

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Not competitive at all at the wires level (legal monopoly), and structurally stable. The regulatory environment is getting tougher (affordability backlash), which is the relevant pressure.

How profitable (ROIC, ROE)? ROE ~9.6% (2025), rising but the lowest among large-cap peers; ROIC ~5.7%, below cost of capital (structural for utilities, but widest gap in the cohort due to ComEd). Allowed distribution ROEs ~8.9% (ComEd) to ~9.6% (NJ/DE/DC); FERC transmission ~10.5%+.

How profitable is the industry / barriers to entry? Industry returns are capped by regulators near cost of capital; barriers to entry are absolute (statutory monopoly). Good, stable, but rent-capped.

Can the business be easily understood? Yes — among the simplest models in equities: rate base × allowed ROE, plus pass-throughs.

Undermined by foreign low-cost labor? No — domestic, fixed-location infrastructure.

Do brands matter? No — captive customers, no brand choice.

Nature of competition / switching costs? No competition; switching costs are total/legal. The “pricing power” is the allowed ROE, set by regulators, and EXC’s is the lowest in the group.

Financial Condition & Balance Sheet

Assets not fully recognized / off-balance-sheet liabilities? Standard utility items: regulatory assets/liabilities, pension/OPEB (~$2.3B pension liability), purchase-power and lease obligations, asset-retirement obligations. Nothing unusual; goodwill is a static $6.63B (mostly Pepco Holdings, never impaired). (Fact.)

How conservative is the accounting? Clean and low-noise post-spin — operating EPS ≈ GAAP EPS, adjustments limited to modest severance/MtM/small impairments. Regulated accounting (ASC 980) is highly standardized. No aggressive run-rate distortions identified. (Interpretation: among the cleanest in the coverage universe.)

How CapEx-hungry? Extremely — this is the defining feature. ~$10B/year capex, ~$41.7B over four years; FCF after capex is negative every year; the build is funded by debt + equity. The capex is the value creation (it enters rate base), but the business cannot self-fund.

Capital Allocation & Management

FCF generation / use / philosophy? Operating cash flow ~$6.25B (2025) is fully consumed by capex (~$8.5B) plus dividends (~$1.6B); the deficit is funded externally. Philosophy: grow rate base, pay a ~60%-payout growing dividend, fund the gap with disciplined debt + minimal-dilution equity (hybrids/converts for equity credit). No buybacks (correct).

Significant acquisitions recently? None since Pepco Holdings (2016). The defining corporate action was the divestiture — the 2022 Constellation spin.

Buying back shares? No — structural net issuer (~1%/yr dilution via ATM/forward equity), appropriate for a heavy-build utility.

Issuing shares to insiders? Routine equity comp only; no unusual insider issuance. ~$3.4B equity planned through 2029 (~40% of incremental capital, <2% of market cap/yr).

Compensation policy / incentive alignment? Strong: AIP = 60% operating EPS + reliability + customer-sat; LTIP = PSUs on Operating ROE / Operating EPS / CFO-Debt under a relative-TSR modifier. No rate-base/capital-deployed metric (removes empire-building incentive). PSUs genuinely missed (83.76% for 2022–24). CEO Butler ~$15.6M, ~70% at-risk. (Fact, per proxy.)

Motivations of management? Incentives point to per-share earnings, ROE, credit, and relative TSR — well-aligned with shareholders. No insider open-market buying (zero signal, typical for a utility).

Valuation & Market Data

ADR, MLP, or K-1 issuer? No — a standard US C-corp common stock (NASDAQ: EXC); 1099 dividends, not K-1.

Dividend policy? ~$1.58/share (2025), ~58% payout of operating EPS, ~3.6% yield, growing ~5–6%/yr toward a ~60% target. Safe and well-covered. (Fact/Interpretation.)

How profitable / net income vs. cash from operations? Net income $2.77B; OCF $6.25B (OCF > NI by D&A and deferred taxes, normal). The meaningful divergence is OCF vs. FCF — FCF is negative after capex, the key structural feature. Do not apply a P/FCF multiple.

Risks & Downside

What would cause the stock to decline? (1) ComEd appeal loss / bad 2028–31 Grid Plan; (2) Pennsylvania affordability regime hardening into structurally lower allowed ROE/equity, spreading to Maryland; (3) interest-rate backup (de-rates the bond proxy + raises financing cost); (4) credit downgrade; (5) multiple compression from the 88th-percentile own-history level.

Risk of catastrophic loss? Very low — diversified, regulated, six-state monopoly with pass-through commodity risk and reliable cash flows.

Chance of total loss? Negligible — a regulated monopoly with a hard asset base, an investment-grade balance sheet, and statutory franchise protection. The realistic downside is a 15–25% de-rating, not impairment.

Recent News & Events

Has the business environment changed recently? Yes, materially: (1) PECO withdrew its PA rate cases (Apr-2026) under affordability pressure — the key event; (2) capex plan raised/rebalanced to $41.7B with $1.5B shifted from distribution into transmission; (3) data-center pipeline doubled to ~18 GW; (4) $350M of 2027 O&M cuts + voluntary separation program announced; (5) PJM capacity prices spiked >1,000%, intensifying the affordability backlash; (6) Truist cut its price target to $49 (Hold, May-2026).

Significant acquisitions? None.

Change in accounting policies? None identified.

Recent changes — new markets, facilities, management? Entry into competitive transmission (MISO Tranche 2.1 bids, Feb-2026); PECO interim-CEO change (Innocenzo); new director DeWalt (Mar-2025). No new service territories (the franchise footprint is fixed).

APPENDIX B — Source Appendix — Exelon Corporation (NASDAQ: EXC)

Primary sources prioritized. Accessed June 2026. Facts reconciled to filings; third-party aggregator data (ROIC.ai, AZI, FactorsToday) cross-checked against primary filings.

Primary — SEC Filings (CIK 0001109357)

Primary — Regulatory

Primary — Company communications

Secondary — Quantitative aggregators (cross-checked to filings)

Secondary — Peer cross-read

Frameworks applied

• Greenwald & Kahn, Competition Demystified — moat-type taxonomy (regulated-monopoly franchise; demand captivity + scale + regulatory incumbency), ROIC-vs-WACC test, market-share stability.
• Chancellor / Marathon, Capital Returns — supply-side capital-cycle analysis adapted for the regulated “breakdown” condition (capex rewarded, under-build risk, asset-growth/dilution anomaly for equity holders).

Price moves are reported as Fact; attributed causes as Interpretation. No price target or buy/sell recommendation appears outside the labeled Claude's Take block.